FRESH-PEF73983-en
COVID-19 vaccine cohort for special populations
ANRS 0001 S COV-POPART
| Name | Country code |
|---|---|
| France | fr |
['Clinical data','Participant-reported health data','Biological data','Socio-demographic data']
Individuals
| Topic | Vocabulary |
|---|---|
| Clinical immunology | health theme |
| Infectious disease medicine | health theme |
| COVID-19 | cim-11 |
{
"level_sex_clusion_I": [
{
"value": "Male",
"concept": {
"vocab": "MeSH",
"vocabURI": "http:\/\/id.nlm.nih.gov\/mesh\/D008297"
}
},
{
"value": "Female",
"concept": {
"vocab": "MeSH",
"vocabURI": "http:\/\/id.nlm.nih.gov\/mesh\/D005260"
}
}
],
"level_age_clusion_I": [
{
"value": "Child, Preschool (2 to 5 years)",
"concept": {
"vocab": "MeSH",
"vocabURI": "http:\/\/id.nlm.nih.gov\/mesh\/D002675"
}
},
{
"value": "Child (6 to 12 years)",
"concept": {
"vocab": "MeSH",
"vocabURI": "http:\/\/id.nlm.nih.gov\/mesh\/D002648"
}
},
{
"value": "Young Adult (19 to 24 years)",
"concept": {
"vocab": "MeSH",
"vocabURI": "http:\/\/id.nlm.nih.gov\/mesh\/D055815"
}
},
{
"value": "Adult (25 to 44 years)",
"concept": {
"vocab": "MeSH",
"vocabURI": "http:\/\/id.nlm.nih.gov\/mesh\/D000328"
}
},
{
"value": "Middle Aged (45 to 64 years)",
"concept": {
"vocab": "MeSH",
"vocabURI": "http:\/\/id.nlm.nih.gov\/mesh\/D008875"
}
},
{
"value": "Aged (65 to 79 years)",
"concept": {
"vocab": "MeSH",
"vocabURI": "http:\/\/id.nlm.nih.gov\/mesh\/D000368"
}
},
{
"value": "Aged, 80 and over (80 years and more)",
"concept": {
"vocab": "MeSH",
"vocabURI": "http:\/\/id.nlm.nih.gov\/mesh\/D000369"
}
}
],
"level_type_clusion_I": "General population",
"level_type_clusion_other": "",
"clusion_I": "",
"clusion_E": ""
}
| Name |
|---|
| Linda;WITTKOP |
| Odile;LAUNAY |
| Paul;LOUBET |
| Name |
|---|
| AGENCE NATIONALE DE RECHERCHES SUR LE SIDA ET LES HEPATITES VIRALES |
| Name |
|---|
| AGENCE NATIONALE DE RECHERCHES SUR LE SIDA ET LES HEPATITES VIRALES |
['Through organizations (health services or institutions, schools, businesses, etc.)']
['{"concept":{"vocabURI":"Other","vocab":"CESSDA"},"value":"Other"}']
Observational Study
| Start | End |
|---|---|
| 2021-01-01 | 2024-01-01 |
['CMG-EC quality system (ISO 9001 certified), consistency checks after data entry, data monitoring according to a monitoring plan: remotely + on site by a specialised CRO (return to source file for data management and verification)']
Via the PRS form, which must be validated by the cohort's Steering Committee and Scientific Board.
{"value":"Restricted access","extLink":[{"title":"COAR","uri":"http://purl.org/coar/access_right/c_16ec"}]}
| Name | |
|---|---|
| Aude;BARQUIN | aude.barquin@inserm.fr |
| Sophie;GUILMIN-CREPON | sophie.guilmin-crepon@aphp.fr |
FRESH-PEF73983-en